IBEX (IBEX) Stock Forecast, Price Target & Predictions
IBEX Stock Forecast
IBEX stock forecast is as follows: an average price target of $24.00 (represents a 25.92% upside from IBEX’s last price of $19.06) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.
IBEX Price Target
The average price target for IBEX (IBEX) is $24.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $29.00 to $20.00. This represents a potential 25.92% upside from IBEX's last price of $19.06.
IBEX Analyst Ratings
According to 3 Wall Street analysts, IBEX's rating consensus is 'Hold'. The analyst rating breakdown for IBEX stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 2 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
IBEX Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 16, 2024 | David Koning | Robert W. Baird | $23.00 | $20.02 | 14.91% | 20.67% |
| Sep 13, 2024 | Daniel Perlin | RBC Capital | $20.00 | $16.73 | 19.55% | 4.93% |
| Apr 19, 2024 | David Koning | Robert W. Baird | $20.00 | $13.16 | 51.98% | 4.93% |
| Sep 14, 2023 | Sector Perform | RBC Capital | $18.00 | $13.79 | 30.53% | -5.56% |
| Jan 06, 2023 | - | Piper Sandler | $29.00 | $25.16 | 15.26% | 52.15% |
| Nov 16, 2022 | - | Piper Sandler | $27.00 | $22.52 | 19.89% | 41.66% |
The latest IBEX stock forecast, released on Sep 16, 2024 by David Koning from Robert W. Baird, set a price target of $23.00, which represents a 14.91% increase from the stock price at the time of the forecast ($20.02), and a 20.67% increase from IBEX last price ($19.06).
IBEX Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 2 | 3 |
| Avg Price Target | $21.50 | $21.50 | $21.00 |
| Last Closing Price | $19.06 | $19.06 | $19.06 |
| Upside/Downside | 12.80% | 12.80% | 10.18% |
In the current month, the average price target of IBEX stock is $21.50, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 12.80% increase as opposed to IBEX's last price of $19.06. This month's average price target is down 0.00% compared to last quarter, and up 2.38% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 13, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
| Sep 18, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Sep 14, 2023 | RBC Capital | Outperform | Sector Perform | Downgrade |
| May 19, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Feb 16, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Jan 06, 2023 | Piper Sandler | Overweight | Overweight | Hold |
| Nov 16, 2022 | RBC Capital | Outperform | Outperform | Hold |
| Nov 16, 2022 | Piper Sandler | Overweight | Overweight | Hold |
| Sep 26, 2022 | Citigroup | Neutral | Neutral | Hold |
IBEX's last stock rating was published by RBC Capital on Sep 13, 2024. The company gave IBEX a "Sector Perform" rating, the same as its previous rate.
IBEX Financial Forecast
IBEX Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $132.63M | $124.61M | $124.43K | $131.60M | $139.39M | $127.88M | - | $20.54M | $132.18M | - | - | $108.77M | $117.18M | - |
| Avg Forecast | $136.00M | $136.50M | $140.70M | $129.60M | $128.91M | $129.67M | $134.63M | $125.22M | $122.27M | $126.97M | $134.93M | $123.84M | $125.89M | $141.49M | $144.41M | $125.60M | $124.14M | $125.65M | $122.42M | $112.72M | $111.32M | $110.52M | $115.23M | $96.80M |
| High Forecast | $136.00M | $136.50M | $140.70M | $129.60M | $128.91M | $129.67M | $134.63M | $125.22M | $122.27M | $126.97M | $136.44M | $124.02M | $125.89M | $141.49M | $144.41M | $125.60M | $124.14M | $125.65M | $122.42M | $112.72M | $111.32M | $110.52M | $115.23M | $96.80M |
| Low Forecast | $136.00M | $136.50M | $140.70M | $129.60M | $128.91M | $129.67M | $134.63M | $125.22M | $122.27M | $126.97M | $133.41M | $123.55M | $125.89M | $141.49M | $144.41M | $125.60M | $124.14M | $125.65M | $122.42M | $112.72M | $111.32M | $110.52M | $115.23M | $96.80M |
| # Analysts | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.98% | 1.01% | 0.00% | 0.93% | 0.97% | 1.02% | - | 0.16% | 1.08% | - | - | 0.98% | 1.02% | - |
IBEX's average Quarter revenue forecast for Mar 24 based on 1 analysts is $126.97M, with a low forecast of $126.97M, and a high forecast of $126.97M. IBEX's average Quarter revenue forecast represents a -4.27% decrease compared to the company's last Quarter revenue of $132.63M (Dec 23).
IBEX EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $100.58M | $94.13M | $13.38K | $23.31M | $21.74M | $18.11M | - | $17.82M | $16.60M | - | - | $5.53M | $13.32M | - |
| Avg Forecast | $33.04M | $33.16M | $34.18M | $31.48M | $31.31M | $31.50M | $32.70M | $30.42M | $29.70M | $30.84M | $32.78M | $30.08M | $30.58M | $34.37M | $35.08M | $30.51M | $13.40M | $13.57M | $13.22M | $21.82M | $12.02M | $11.93M | $12.44M | $4.00M |
| High Forecast | $33.04M | $33.16M | $34.18M | $31.48M | $31.31M | $31.50M | $32.70M | $30.42M | $29.70M | $30.84M | $33.14M | $30.13M | $30.58M | $34.37M | $35.08M | $30.51M | $13.40M | $13.57M | $13.22M | $26.19M | $12.02M | $11.93M | $12.44M | $4.79M |
| Low Forecast | $33.04M | $33.16M | $34.18M | $31.48M | $31.31M | $31.50M | $32.70M | $30.42M | $29.70M | $30.84M | $32.41M | $30.01M | $30.58M | $34.37M | $35.08M | $30.51M | $13.40M | $13.57M | $13.22M | $17.46M | $12.02M | $11.93M | $12.44M | $3.20M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 3.07% | 3.13% | 0.00% | 0.68% | 0.62% | 0.59% | - | 1.31% | 1.26% | - | - | 0.46% | 1.07% | - |
1 analysts predict IBEX's average Quarter EBITDA for Mar 24 to be $30.84M, with a high of $30.84M and a low of $30.84M. This is -69.33% lower than IBEX's previous annual EBITDA (Dec 23) of $100.58M.
IBEX Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $6.08M | $7.42M | $12.12K | $11.70M | $1.86M | $4.31M | - | $6.60M | $8.46M | - | - | $-3.42M | $2.49M | - |
| Avg Forecast | $12.52M | $12.08M | $9.44M | $9.26M | $11.64M | $11.20M | $8.55M | $8.38M | $9.26M | $9.17M | $8.88M | $6.39M | $8.64M | $6.81M | $7.13M | $4.75M | $8.13M | $7.17M | $6.20M | $4.92M | $2.90M | $4.06M | $5.15M | $-2.47M |
| High Forecast | $12.52M | $12.08M | $9.44M | $9.26M | $11.64M | $11.20M | $8.55M | $8.56M | $9.26M | $9.17M | $9.23M | $7.10M | $8.64M | $6.81M | $7.13M | $4.75M | $8.13M | $7.17M | $6.20M | $5.91M | $2.90M | $4.06M | $5.15M | $-1.98M |
| Low Forecast | $12.52M | $12.08M | $9.44M | $9.26M | $11.64M | $11.20M | $8.55M | $8.38M | $9.26M | $9.17M | $8.53M | $6.22M | $8.64M | $6.81M | $7.13M | $4.75M | $8.13M | $7.17M | $6.20M | $3.94M | $2.90M | $4.06M | $5.15M | $-2.97M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.68% | 1.16% | 0.00% | 1.72% | 0.26% | 0.91% | - | 0.92% | 1.37% | - | - | -0.84% | 0.48% | - |
IBEX's average Quarter net income forecast for Mar 24 is $9.17M, with a range of $9.17M to $9.17M. IBEX's average Quarter net income forecast represents a 50.98% increase compared to the company's last Quarter net income of $6.08M (Dec 23).
IBEX SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $24.86M | $23.04M | $23.72K | $89.52M | $96.46M | $91.39M | - | $92.72M | $95.12M | - | - | $78.45M | $82.98M | - |
| Avg Forecast | $76.42M | $76.70M | $79.06M | $72.83M | $72.44M | $72.86M | $75.65M | $70.36M | $68.71M | $71.35M | $75.82M | $69.59M | $70.74M | $79.51M | $81.15M | $70.58M | $86.90M | $87.95M | $85.69M | $78.90M | $77.92M | $77.36M | $80.66M | $4.48M |
| High Forecast | $76.42M | $76.70M | $79.06M | $72.83M | $72.44M | $72.86M | $75.65M | $70.36M | $68.71M | $71.35M | $76.67M | $69.69M | $70.74M | $79.51M | $81.15M | $70.58M | $86.90M | $87.95M | $85.69M | $78.90M | $77.92M | $77.36M | $80.66M | $5.37M |
| Low Forecast | $76.42M | $76.70M | $79.06M | $72.83M | $72.44M | $72.86M | $75.65M | $70.36M | $68.71M | $71.35M | $74.97M | $69.43M | $70.74M | $79.51M | $81.15M | $70.58M | $86.90M | $87.95M | $85.69M | $78.90M | $77.92M | $77.36M | $80.66M | $3.58M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.33% | 0.33% | 0.00% | 1.13% | 1.19% | 1.29% | - | 1.05% | 1.11% | - | - | 1.01% | 1.03% | - |
IBEX's average Quarter SG&A projection for Mar 24 is $71.35M, based on 1 Wall Street analysts, with a range of $71.35M to $71.35M. The forecast indicates a 187.04% rise compared to IBEX last annual SG&A of $24.86M (Dec 23).
IBEX EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | $0.34 | $0.41 | - | $0.64 | $0.10 | $0.24 | - | $0.36 | $0.46 | - | - | $-0.21 | $0.14 | - |
| Avg Forecast | $0.71 | $0.69 | $0.54 | $0.53 | $0.66 | $0.64 | $0.48 | $0.47 | $0.53 | $0.52 | $0.50 | $0.36 | $0.49 | $0.39 | $0.40 | $0.27 | $0.45 | $0.40 | $0.34 | $0.27 | $0.16 | $0.22 | $0.29 | $0.16 |
| High Forecast | $0.71 | $0.69 | $0.54 | $0.53 | $0.66 | $0.64 | $0.48 | $0.49 | $0.53 | $0.52 | $0.52 | $0.40 | $0.49 | $0.39 | $0.40 | $0.27 | $0.45 | $0.40 | $0.34 | $0.27 | $0.16 | $0.22 | $0.29 | $0.16 |
| Low Forecast | $0.71 | $0.69 | $0.54 | $0.53 | $0.66 | $0.64 | $0.48 | $0.47 | $0.53 | $0.52 | $0.48 | $0.35 | $0.49 | $0.39 | $0.40 | $0.27 | $0.45 | $0.40 | $0.34 | $0.27 | $0.16 | $0.22 | $0.29 | $0.16 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.68% | 1.13% | 0.00% | 1.66% | 0.25% | 0.89% | - | 0.91% | 1.34% | - | - | -0.93% | 0.49% | - |
According to 1 Wall Street analysts, IBEX's projected average Quarter EPS for Mar 24 is $0.52, with a low estimate of $0.52 and a high estimate of $0.52. This represents a 52.94% increase compared to IBEX previous annual EPS of $0.34 (Dec 23).
IBEX Forecast FAQ
Is IBEX a good buy?
No, according to 3 Wall Street analysts, IBEX (IBEX) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 33.33% of IBEX's total ratings.
What is IBEX's price target?
IBEX (IBEX) average price target is $24 with a range of $20 to $29, implying a 25.92% from its last price of $19.06. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will IBEX stock go up soon?
According to Wall Street analysts' prediction for IBEX stock, the company can go up by 25.92% (from the last price of $19.06 to the average price target of $24), up by 52.15% based on the highest stock price target, and up by 4.93% based on the lowest stock price target.
Can IBEX stock reach $30?
IBEX's average twelve months analyst stock price target of $24 does not support the claim that IBEX can reach $30 in the near future.
What is IBEX's current price target trend?
2 Wall Street analysts forecast a $21.5 price target for IBEX (IBEX) this month, up 12.80% from its last price of $19.06. Compared to the last 3 and 12 months, the average price target increased by 12.80% and increased by 10.18%, respectively.
What are IBEX's analysts' financial forecasts?
IBEX's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $518.42M (high $518.42M, low $518.42M), average EBITDA is $125.94M (high $125.94M, low $125.94M), average net income is $39.78M (high $39.95M, low $39.78M), average SG&A $291.31M (high $291.31M, low $291.31M), and average EPS is $2.25 (high $2.27, low $2.25). IBEX's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $542.8M (high $542.8M, low $542.8M), average EBITDA is $131.86M (high $131.86M, low $131.86M), average net income is $43.3M (high $43.3M, low $43.3M), average SG&A $305.02M (high $305.02M, low $305.02M), and average EPS is $2.46 (high $2.46, low $2.46).
Did the IBEX's actual financial results beat the analysts' financial forecasts?
Based on IBEX's last annual report (Jun 2023), the company's revenue was $523.12M, which missed the average analysts forecast of $661.53M by -20.92%. Apple's EBITDA was $397.68M, beating the average prediction of $143.95M by 176.27%. The company's net income was $31.58M, missing the average estimation of $35.46M by -10.95%. Apple's SG&A was $88.66M, missing the average forecast of $388.87M by -77.20%. Lastly, the company's EPS was $1.74, missing the average prediction of $2 by -13.02%. In terms of the last quarterly report (Dec 2023), IBEX's revenue was $132.63M, missing the average analysts' forecast of $134.93M by -1.70%. The company's EBITDA was $100.58M, beating the average prediction of $32.78M by 206.85%. IBEX's net income was $6.08M, missing the average estimation of $8.88M by -31.60%. The company's SG&A was $24.86M, missing the average forecast of $75.82M by -67.22%. Lastly, the company's EPS was $0.34, missing the average prediction of $0.503 by -32.47%